Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
AZD3355, a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action
Journal of Pharmacology and Experimental Therapeutics, 08/05/09
Lehmann A et al. – AZD3355 likely inhibits TLESR through stimulation of peripheral GABAB receptors and may offer a potential new approach to treatment of GERD.
Related Articles
Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
Health and Quality of Life Outcomes, 10/22/09
Relevance Score: 89%%
Proton Pump Inhibitors in the Management of GERD
Journal of Gastrointestinal Surgery, 10/01/09
Relevance Score: 89%%
Bronchial hyperreactivity in non-atopic children with asthma and reflux: Effect of anti-reflux treatment
Pediatric Pulmonology, 10/22/09
Relevance Score: 88%%
Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)
Inflammation & Allergy - Drug Targets, 10/12/09
Relevance Score: 88%%
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care
Alimentary Pharmacology and Therapeutics, 10/26/09
Relevance Score: 87%%
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09
Sponsor
Article Search
Sponsor


See Latest Articles


